Voluntary recall issued for lidocaine cream and liquid gel products
Lidocaine topical cream and liquid gel products are being recalled as the lidocaine amount is higher than the label states.
List view / Grid view
Lidocaine topical cream and liquid gel products are being recalled as the lidocaine amount is higher than the label states.
The EMA has requested that liposomal medication names be changed to avoid the risk of confusion.
The pharmaceutical industry is set to face some major changes in the near future, to improve the quality of returned drugs and medications.
Two lots of Kogenate® FS vials actually contain the FVIII hemophilia A treatment, Jivi®.
The successful pilot programme could represent an important step forward in biopharmaceutical supply chain innovation.
Pharmaceutical packaging in China has increased at a rate of 10 percent in recent years and is predicted to continue high growth.
New guidance drafts have been announced by the FDA to improve patients understanding and keep information consistent.
Substandard and counterfeit drugs can negatively impact the pharmaceutical industry and patients. Here, we investigate counterfeits in south-east Asia and possible solutions.
Effective drug serialisation and identification is essential for improving the safety of medicines and combatting counterfeits. The Falsified Medicines Directive’s new requirements promise to crack down on the impacts of unsafe drugs. Neil Piper discusses the human cost of falsified medicines and how companies need to increase traceability of individual…
Pharmaceutical company Pfizer was able to target the distribution of counterfeit Viagra in Hong Kong through serialisation technology.
Whether by ignorance of the latest best practices, or willful disregard for patient safety, the results of careless practice can often be fatal. The articles in this in-depth focus highlight how regulatory bodies are taking action to raise the industry’s game.
The latest research and developments from Pharma and Biopharma industry experts.
DHL Supply Chain is investing millions of dollars to expand its pharmaceutical and medical device distribution network in the US.
The increasing complexity of formulations and active biological products raises new challenges for pre-filled syringe development. James Mellman, Device Manager at Novartis, speaks to Nikki Withers about the challenges of selecting the right primary packaging for injectable formulations and how he has learnt to expect the unexpected.
In this issue we explore reasons behind critical key drug shortages in the EU, whether viability methods effectively detect all viable organisms and how companies can future-proof their digital technologies ahead of Brexit. Also included are articles on higher order protein structure, FMD compliance and Raman spectroscopy.